Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting

NCT: NCT05843864 · COMPLETED

NCT IDNCT05843864
StatusCOMPLETED
Start Date2023-06-07
Completion2025-08-14
SponsorBrooke Army Medical Center (FED)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to compare photobiomodulation therapy (PBMT) in addition to standard of care in the treatment of tibial and metatarsal bone stress injuries in a military training setting. Participants will all receive usual care and also be randomized to either active or sham photobiomodulation therapy. Effectiveness will be assessed based on time to return to duty and measures of pain and function. * Participants will receive care for a maximum of 6 weeks. * Participants will have follow-up through 4 months (or graduation/dismissal from training, whichever comes first).

Frequently Asked Questions

What is Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting?

Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting is a clinical trial registered under NCT05843864. Current status: COMPLETED.

What is the status of NCT05843864?

The current status of NCT05843864 (Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting) is: COMPLETED.

When did Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting start?

Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting started on 2023-06-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.